Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells

J Org Chem. 2001 Aug 24;66(17):5655-63. doi: 10.1021/jo005757n.

Abstract

Current chemotherapy protocols that include fluoropyrimidines, such as 5-fluorouracil (5-FU), are limited by the development of chemoresistance during the course of treatment. Our laboratory has developed a novel class of fluoropyrimidines, FdUMP[N], that are oligodeoxynucleotides (ODNs) composed of some number, N, of 5-fluoro-2'-deoxyuridine-5'-O-monphosphate (FdUMP) nucleotides. Novel synthetic procedures are described that permit conjugation of folic acid to the 5'-OH of FdUMP[10] via a phosphodiester linkage using automated synthesis. The synthetic methods developed are generally applicable for ODN conjugation with folic acid. The folic acid conjugate FA-FdUMP[10] showed improved cytotoxicity toward human colorectal tumor cells (H630), and 5-FU-resistant colorectal tumor cells (H630-10). Enhanced cytotoxicity was observed for FA-FdUMP[10] relative to nonconjugated FdUMP[10] for cells grown under folate-restricted conditions, consistent with cellular uptake being, in part, receptor-mediated. Folate receptor alpha (FRalpha) mRNA was shown by RT-PCR to be overexpressed 26.3-fold in 5-FU-resistant H630-10 cells relative to H630 cells. Thus, FA-FdUMP[N] may prove useful for the treatment of 5-FU-resistant malignancies.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / toxicity*
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / genetics
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / metabolism
  • Drug Delivery Systems
  • Drug Resistance, Neoplasm
  • Fluorodeoxyuridylate / administration & dosage
  • Fluorodeoxyuridylate / analogs & derivatives*
  • Fluorodeoxyuridylate / chemical synthesis*
  • Fluorodeoxyuridylate / toxicity*
  • Fluorouracil / pharmacology
  • Folate Receptors, GPI-Anchored
  • Folic Acid / administration & dosage
  • Folic Acid / analogs & derivatives*
  • Folic Acid / toxicity
  • Humans
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics
  • Membrane Transport Proteins*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Cell Surface*
  • Thymidylate Synthase / antagonists & inhibitors
  • Thymidylate Synthase / biosynthesis
  • Thymidylate Synthase / genetics
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • FdUMP(10)
  • Folate Receptors, GPI-Anchored
  • Membrane Proteins
  • Membrane Transport Proteins
  • RNA, Messenger
  • Receptors, Cell Surface
  • SLC19A2 protein, human
  • Fluorodeoxyuridylate
  • Folic Acid
  • Thymidylate Synthase
  • Fluorouracil